Chris Schott

3 results

Johnson & Johnson says  it expects full-year sales for 2019 in the range of $80.4bn   to $81.2bn

Johnson & Johnson (J&J) on Tuesday forecast 2019 sales that fell short of analysts’ estimates as the healthcare conglomerate faces increasing (...)

Merck earnings were boosted by new immuno-oncology drug Keytruda  and Januvia diabetes treatment. Photograph: iStock

US pharma giant Merck reported better-than-expected quarterly earnings, fuelled by sales of its new Keytruda immuno-oncology drug and Januvia diabetes(...)

Shares in Irish drug company Amarin slumped as much as 64 per cent on Thursday, a day after an advisory committee to the US Food and Drug Administrati(...)